These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37113190)

  • 1. Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis.
    Xu W; Bai Z; Shang Y; Wang J; Wong Y; Qi X
    Therap Adv Gastroenterol; 2023; 16():17562848231167858. PubMed ID: 37113190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Review on the Efficacy and Safety of Vonoprazan in the Management of Gastric Acid-Related Diseases.
    Padwale V; Kirnake V; Daswani R; Kodmalwar A; Gupta A
    Cureus; 2024 Jul; 16(7):e64777. PubMed ID: 39156336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2020 Feb; 99(9):e19357. PubMed ID: 32118778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric endoscopic submucosal dissection-induced ulcer: an updated systematic review and meta-analysis.
    Chen L; Jiang D; Hu D; Cui X
    BMC Gastroenterol; 2024 Mar; 24(1):110. PubMed ID: 38491413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data.
    Marabotto E; Ziola S; Savarino V; Giannini EG; Furnari M; Bodini G; Zingone F; Ghisa M; Barberio B; Zentilin P; Savarino E
    Clin Exp Gastroenterol; 2020; 13():99-104. PubMed ID: 32346304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers vs. Proton Pump Inhibitors for Peptic Ulcer with or without
    Ouyang M; Zou S; Cheng Q; Shi X; Zhao Y; Sun M
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.
    Liu C; Feng BC; Zhang Y; Li LX; Zuo XL; Li YQ
    J Dig Dis; 2019 Oct; 20(10):503-511. PubMed ID: 31414725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vonoprazan-associated
    Ouyang M; Zou S; Cheng Q; Shi X; Zhao Y; Sun M
    Ther Adv Drug Saf; 2024; 15():20420986241260211. PubMed ID: 39091466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.
    Kang H; Kim BJ; Choi G; Kim JG
    Medicine (Baltimore); 2019 Jun; 98(24):e15860. PubMed ID: 31192917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
    Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J
    Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Use of Vonoprazan and Proton Pump Inhibitors for the Treatment of Peptic Ulcers Resulting from Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis.
    He HS; Li BY; Chen QT; Song CY; Shi J; Shi B
    Med Sci Monit; 2019 Feb; 25():1169-1176. PubMed ID: 30755541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis.
    Jiang X; Li J; Xie J; Liang Z; Wan N; Jiang J; Zhang T; Wu Y
    Front Pharmacol; 2019; 10():1055. PubMed ID: 31607912
    [No Abstract]   [Full Text] [Related]  

  • 13. Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review.
    Miyazaki H; Igarashi A; Takeuchi T; Teng L; Uda A; Deguchi H; Higuchi K; Tango T
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1316-1328. PubMed ID: 30883868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2019 Feb; 98(8):e14381. PubMed ID: 30813139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.
    Yang X; Li Y; Sun Y; Zhang M; Guo C; Mirza IA; Li YQ
    Dig Dis Sci; 2018 Feb; 63(2):302-311. PubMed ID: 29282636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis.
    Simadibrata DM; Syam AF; Lee YY
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2217-2228. PubMed ID: 36181401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.
    Kagawa T; Iwamuro M; Ishikawa S; Ishida M; Kuraoka S; Sasaki K; Sakakihara I; Izumikawa K; Yamamoto K; Takahashi S; Tanaka S; Matsuura M; Hasui T; Wato M; Inaba T
    Aliment Pharmacol Ther; 2016 Sep; 44(6):583-91. PubMed ID: 27464849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.
    Simadibrata DM; Lesmana E; Fass R
    J Gastroenterol Hepatol; 2024 May; 39(5):796-805. PubMed ID: 38263507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.
    Miwa H; Igarashi A; Teng L; Uda A; Deguchi H; Tango T
    J Gastroenterol; 2019 Aug; 54(8):718-729. PubMed ID: 30919071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vonoprazan on gastric PH and clinical course after gastric ESD: A retrospective and prospective study.
    Suto D; Yoshida M; Otake T; Ichiishi E; Sato K; Murata K; Ebinuma H; Odaira H; Suzuki Y; Kohgo Y
    Ann Med Surg (Lond); 2020 Dec; 60():27-30. PubMed ID: 33101669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.